These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32651051)

  • 1. Electroconvulsive Therapy Pulse Amplitude and Clinical Outcomes.
    Abbott CC; Quinn D; Miller J; Ye E; Iqbal S; Lloyd M; Jones TR; Upston J; Deng Z; Erhardt E; McClintock SM
    Am J Geriatr Psychiatry; 2021 Feb; 29(2):166-178. PubMed ID: 32651051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplitude-determined seizure-threshold, electric field modeling, and electroconvulsive therapy antidepressant and cognitive outcomes.
    Abbott CC; Miller J; Farrar D; Argyelan M; Lloyd M; Squillaci T; Kimbrell B; Ryman S; Jones TR; Upston J; Quinn DK; Peterchev AV; Erhardt E; Datta A; McClintock SM; Deng ZD
    Neuropsychopharmacology; 2024 Mar; 49(4):640-648. PubMed ID: 38212442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study.
    Spaans HP; Verwijk E; Comijs HC; Kok RM; Sienaert P; Bouckaert F; Fannes K; Vandepoel K; Scherder EJ; Stek ML; Kho KH
    J Clin Psychiatry; 2013 Nov; 74(11):e1029-36. PubMed ID: 24330903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Links between electroconvulsive therapy responsive and cognitive impairment multimodal brain networks in late-life major depressive disorder.
    Qi S; Calhoun VD; Zhang D; Miller J; Deng ZD; Narr KL; Sheline Y; McClintock SM; Jiang R; Yang X; Upston J; Jones T; Sui J; Abbott CC
    BMC Med; 2022 Dec; 20(1):477. PubMed ID: 36482369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial.
    Brakemeier EL; Merkl A; Wilbertz G; Quante A; Regen F; Bührsch N; van Hall F; Kischkel E; Danker-Hopfe H; Anghelescu I; Heuser I; Kathmann N; Bajbouj M
    Biol Psychiatry; 2014 Aug; 76(3):194-202. PubMed ID: 24462229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.
    Sackeim HA; Dillingham EM; Prudic J; Cooper T; McCall WV; Rosenquist P; Isenberg K; Garcia K; Mulsant BH; Haskett RF
    Arch Gen Psychiatry; 2009 Jul; 66(7):729-37. PubMed ID: 19581564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes.
    Deng ZD; Argyelan M; Miller J; Quinn DK; Lloyd M; Jones TR; Upston J; Erhardt E; McClintock SM; Abbott CC
    Mol Psychiatry; 2022 Mar; 27(3):1676-1682. PubMed ID: 34853404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically insubstantial cognitive side effects of bitemporal electroconvulsive therapy at 0.5 msec pulse width.
    Warnell RL; Swartz CM; Thomson A
    Ann Clin Psychiatry; 2011 Nov; 23(4):257-62. PubMed ID: 22073382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.
    Sackeim HA; Prudic J; Nobler MS; Fitzsimons L; Lisanby SH; Payne N; Berman RM; Brakemeier EL; Perera T; Devanand DP
    Brain Stimul; 2008 Apr; 1(2):71-83. PubMed ID: 19756236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Venlafaxine in Geriatric Depression: Phase 1 of the PRIDE Study.
    Lisanby SH; McClintock SM; Alexopoulos G; Bailine SH; Bernhardt E; Briggs MC; Cullum CM; Deng ZD; Dooley M; Geduldig ET; Greenberg RM; Husain MM; Kaliora S; Knapp RG; Latoussakis V; Liebman LS; McCall WV; Mueller M; Petrides G; Prudic J; Rosenquist PB; Rudorfer MV; Sampson S; Teklehaimanot AA; Tobias KG; Weiner RD; Young RC; Kellner CH;
    Am J Geriatr Psychiatry; 2020 Mar; 28(3):304-316. PubMed ID: 31706638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial.
    Loo CK; Katalinic N; Garfield JB; Sainsbury K; Hadzi-Pavlovic D; Mac-Pherson R
    J Affect Disord; 2012 Dec; 142(1-3):233-40. PubMed ID: 22858219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive function after electroconvulsive therapy for depression: relationship to clinical response.
    Anderson IM; McAllister-Williams RH; Downey D; Elliott R; Loo C
    Psychol Med; 2021 Jul; 51(10):1647-1656. PubMed ID: 32102725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electric Field, Ictal Theta Power, and Clinical Outcomes in Electroconvulsive Therapy.
    Miller J; Jones T; Upston J; Deng ZD; McClintock SM; Erhardt E; Farrar D; Abbott CC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Jul; 8(7):760-767. PubMed ID: 36925066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory, attention, and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression.
    Fujita A; Nakaaki S; Segawa K; Azuma H; Sato K; Arahata K; Otsuki K; Hori M; Mochida Y; Uchida M; Yamada T; Nakamura C; Akechi T; Furukawa TA
    J ECT; 2006 Jun; 22(2):107-12. PubMed ID: 16801825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: a review.
    Verwijk E; Comijs HC; Kok RM; Spaans HP; Stek ML; Scherder EJ
    J Affect Disord; 2012 Nov; 140(3):233-43. PubMed ID: 22595374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-frequency rTMS inhibits the anti-depressive effect of ECT. A pilot study.
    Buchholtz PE; Ashkanian M; Hjerrild S; Hauptmann LK; Devantier TA; Jensen P; Wissing S; Thorgaard MV; Bjerager L; Lund J; Alrø AJ; Speed MS; Brund RBK; Videbech P
    Acta Neuropsychiatr; 2020 Dec; 32(6):328-338. PubMed ID: 32713367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and Long-term Cognitive Outcomes in Patients With Major Depression Treated With Electroconvulsive Therapy.
    Vasavada MM; Leaver AM; Njau S; Joshi SH; Ercoli L; Hellemann G; Narr KL; Espinoza R
    J ECT; 2017 Dec; 33(4):278-285. PubMed ID: 28617690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulus pulse-frequency-dependent efficacy and cognitive adverse effects of ultrabrief-pulse electroconvulsive therapy in patients with major depression.
    Roepke S; Luborzewski A; Schindler F; Quante A; Anghelescu I; Heuser I; Bajbouj M
    J ECT; 2011 Jun; 27(2):109-13. PubMed ID: 20938351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.